COVID-19 Booster and IIV Schedule in Immunocompromised Hosts
COVID-19 Booster and IIV Schedule in Immunocompromised Hosts
Recruiting · NCT06599658 · Registry updated 2026-03-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| COVID-19 Booster and IIV Schedule in Immunocompromised Hosts | COVID-19, Coronaviridae Infections, Digestive System Diseases, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, digestive system disorder, gastroenteritis, immune system disorder, inflammatory bowel disease, influenza, intestinal disorder, lung disorder, musculoskeletal system disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, rheumatic disorder, rheumatoid arthritis, viral infectious disease, viral pneumonia | Recruiting | Phase 2 | 2026-03-10 | NCT06599658 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre hospitalier de l'Université de Montréal (CHUM) | Montreal | Canada | 11 |
| Maisonneuve -Rosemont Installation | Montreal | Canada | 1 |
| Research Institute of McGill University Health Centre | Montreal | Canada | 2 |